Registered Dumber.. 06641016 Charity numbgr.. 1126927 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limited by Guarantee) TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 CONTENTS Page Reference and Administrative Details of the Charity. its Trustees and Advisers Trust¢es' Rèport Indopondont Auditor's Rgport on tha Financ•al Statements Statsmènt of Flnan¢lal A¢tlvbtl•8 2-11 12-15 16 Balance Sh88t 17-18 Statement of Cash Flows Not•8 to tho Financlal Statsments 20-36 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2024 Trust88S Professor David Maahs, President Dr Jannet Svensson (appointed 19 October 20241 Dr Jamie Wood. Secretary General DT Sabine Hofer Dr Ferqus Cameron (appointed 19 October 20241 Company regl8tered number IJ6641016 CharSty rogl$torgd numbor 1126927 ReglBtsred offlcè Ellenborough House Wellinglon Street Cheltenham Glou¢e$lershire GLSO 1YD Management Company l K.l.T. Grtsjp GmbH PrInci￿1 Offlc• Company sacrntary Dr Jamie Wood Indopondont auditor Wilkes Tranler & Co Limited Chartered Aecountsnls Slalulory Auditors Brook House Moss Grove Kingsinford West Midlands DY6 9HS Bank•r¥ Commwzbank Berfin-Gedachtniskirche Kurftsrstendamm 237 10719 Berlin Gemiany Lloyds Bank PIC Rotunda Montpellier Cheltenham Gloucestershire GL50 1SH Page 1 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees under Charity Law, vtho are also the Directors under Company Law, present their report and the financial statements of the Charity for the period ended 31 December 2024. This report has been prepared in accordance with the special provisbons ielating lo companies subject lo the small companies regime wlhin Part 15 of the Companies Act 2006. The Inlemalional s￿Iety for Paedialri¢ and Adolescent Diabetes - ISPAD - is a ¢harilable company, limited by guarantee, incorporated on 8 July 2008 Iregistration number 066410161 and reglstered as a charity on 25 November 2008 (charity number 11269271. STRUCTURE, GOVERNANCE ANO MANAGEMENT Govgrning Document The Intemational Society for Paediatri¢ and Adole$cent Diabetes IISPAO or Ihe Society) 1$ governed by ils Memorandum and Arb'cles of Association dated 8 July 2008 (last amended 13 June 20231,. and the UK Charity Governance Code. Prlnclpal Actlvlty ISPADS Overall mission is to bring together professionals from various disciplines wilh an interest in clinical care. $cience, education. and advocacy to prevent, treat or cure all fomis ol diabetes in youth by promoting nebNorking and collaboration. The principal ath'vity of ISPAD is to improve the lives ol children, adolescents and young adults wlh diabetes worldwide, which is accomplished by providing forums, both written Iguidelinesl and face-to- face Iscienlific meetings, science schools for physicians ancj for allied healthcare professionals, and poslgraduale courses). lo physicians and healthcare professionals vh)0 provide care for young people wlh tjiabeles. To advance these aims further. ISPAD advocates thfoughoul the wodd for the appropriate provision of medical care and assists international organisations and health services in Ihe delivery of educational and promotional material for all children and adolescents diabetes. Organ18ational Manag•m•nt Each officer ol the Charty has a rc4e and responsibilib.es that are enumerated In the governing document. The Society's locus on Science. Advocacy and Education is ensured by the officers of the Society who serve as Trustees. They have the ultimate responsibility for fiscal and other decisions in accordance ¥Mth the Memorandum and Artides of Associabon, and any b￿aWS. They consult with the advisory council composed of members of the Society elected each year at the Annual Conference. Advisory council members are specifi'cally sought from different regions of the worfd so that they are Tepresenlalive of the membership as a whole. The advisory council formally meets the board tw'ce each year. Between meetings infom)alion is exchanged by e-mail and regular conference calls. The disseminalion of infomi*ion on important issues does not need lo wail for formal meetings. The Trustees retain an organisalional management group IK.I.T. Group GmbH, Bedin, Gemianyl who deal wlh the day-lo-day activities of the Society and adwses the Trustees in thi5 regard. They have the ability to allocate their employees in any manner that best serves the Society and are granted a license lo organise and manage the Annual cOnfe￿nce. the venue for vthich is selected by the Executive Board. K.l.T. Group reviews the locations, budgets and logists'cs for the Socty and signs the contracts be￿een the management group and venues and exhibitors. K.l.T. Group also collaborales and prowdes logists.cal support to the local conveners and international Scientific Commrttee, which creates the scientific program and selects Speakers. The management group maintsins for the S(Kiety records of da￿t￿daY financial transactions and provides reports to the Treasurer and other Trustees at regular interyals. K.l.T. Group processes receipts and transfers funds from the Soaety's accounts (used for da￿t￿aY acti¥￿'eS) wth the approval of the Treasurer, or the Trustees as a whole, during Trustee meetings or after discussions wth Tnjstees. They organise the venue and related acliwb.es for Directors. meebngs. The Chanty retains both an accounkn.ng firm and solicitors. These advise the Trustees on govemance, legal, anij financial issues. Page 2 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Racruitmant and Trnining of Trustees The Trustees of the Society are the current serving officers of the Society. The Trustees are elected by the members at the Annual Conference. The processes for nomination and election of the Trustees are outlined in the Article5 and Memorandum (amended 12 October 2012 to allow electronic vots"ngl. Trustees have been members of the Society for many years and have cOntnb￿ed lo the Society in many areas." e.g. serving on the Advisory Council. organising one or more of the Annual Scientific meetings. science schools or postgraduate Courses. Trustees have contributed to the Societys efforts in Scien￿, Education and Advocacy, vthich are the pillars of the Society. Newly elected Tru5tee5 spend one year as Truste￿leCt and attend the BoardlTruslee meeting5 to gain experience in the Society's acb'vilies. charrty govemance. finances. grant processinglapprovals and other issues involving the organisalion an¢J running of the Society. Trustees musl be members in good standing of the Society and have participated in the Society's activrtj'es in leadership fdes. They receive fomial infomiation about the role and responsibilities of a Trustee, and undertake self-paced learning from documents available through the Charity Commis510n. The year Spent serving as Trustee￿leCt allows on the job experience, guidance and education from the current Trustees prior lo assuming the responsibilty of a Trustee. Structure and Relallon$hlps The Truslees18oard of Directors communicate wth each other lusualty via email) almost daily on the management and direction ol the Charity- A regular fornial video conlerence meeting 1$ arranged monthly between the Officers and the Administration Company. The Trustees retsin an organisational management gr￿P to assist the actual day-lerday management of the Charity and the Board has direct oversighl of their activth'es. The Society Contracts wf(h the management group to organise and manage the Annual Conference. The management group also provide material support for meetings, organises the Annual Report wth the Trustees, vknich is prepared for distribution at the Annual General Meeting land available for consultation in the rnember area on the ISPAD web51tel and provides a ptsslconference report for the Trustees after the Annual Conference. Fomial management reports are presenled to the Truslees at facfr1￿face meetings al least twce per year. A written report is presented to the Trustees and members at the Annual General Meeting. Information is exchanged by &mail or telephone frequentty on an 'as needed. basis. Financial reports are given to the Treasurer regulady, and the Trustees are updated regulady. The Trustees, on behalf of the StKiety. V•Drked on new joumal pathership opportunibes and established in June 2024 a contract wlh Karger. as the new publisher of the Society's joumal. Hormone Research in Paedialrics. lo provide subscriptions to the journal to all ISPAD members. Subscription to the Joumal Hormone Research in Paedialrics published by Karger is provided for all ISPAD members. Members have full online access, they wll be nominated lo the Editorial Board of the joumal, the ISPAD Guidelines and other Society reports will be published in the journal. The Society has estsblished agreements of cooperation. collatrAYation and Memoranda of Understanding wlh other Charities, companies and Medical Professional Organisations with similar objectives and aims on a need's basis. The Trustees contract for facilty Space. audiTrvisual supplie5 and support. and lood for the Winter admini5tralion meeting lusualty held dunng the inlemab.onal ¢onferen¢e on Advanced Technologies & T￿atMentS for Diabetes IATTDI in Europe) and the Summer meeting usually held during the American Diabetes Association Annual Scientific Meeb'ng IADAI in the United States of America. Page 3 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees set poliaes and guidelines for ￿ganising and running the Annual Conference. The Trustees, on behalf of the Society, provide scientific oversight and wrsrk dosely wth the conveners and international scientific committee on the pro9ram ol the Annual Conference. Rlsk Managom•nt The TrLJStees ol ISPAD are committed lo the Sw'ety's missi¢)n and have joined its board be¢ause they want lo help the charity most effectively carry out its mission for the benefit of children, adolescents, young people and families with diabetes. Trustees fully recognize that meebng their charitys stated public benefit is an ongoing requirement, understand their roles and legal responsibilities. and are committed lo good governance. and wsh to eontribule to ISPAD'S continued improvement. The board acts integrity. adopting values and ¢reating a ¢utture that helps a¢hieve the organisalion's charitsble purposes. The boartj 1$ aware of the importance of the public's confidence and trust in charities, and trustees undertake their duties accordingly. Trustees have the ulb'mate fiduciary responsiblty for managing ISPAO'S funds and assets, protecting ils repulats'on. and maintsining the respect of beneficiaries. other stakeholders and the public by behaving wlh integrity al all times. even when difficult or unpopular decisions a￿ required. The board leads the OTganisation in being transparent and accountable. The charity is open in its work, unless there is good reason for it not to be. The Publ￿'S trust that a charity is delivering a public benefit 15 fundamental lo ils reputation and success. Making 3c¢ounlability real. through genuine and open two-way communication that celebrates suecesses and demonslrales wllingness lo leam from mistskes. helps lo build this trust and confidence and eam legibmacy. OUR VISION, MISSION, AND VALUES Our Vislon A better for children. adolescents and young adults diabetes. Ml88lon Statom8nt To bring together professionals from various disciplines wth an interest in dinical care, science, education and advocacy to prevent. treat or cure all forms of diabetes in youth. By promoting networking and collaboration. ￿r aims a￿.. To ensure appropriate treatment is available, induding medication, self-monitoring equipment and supplies., To increase awareness of all types of diabetes and prevent delayed diagnosis.. To reduce the morbidity and mortality caused by acute and chronic complications., To ensure provision of edu¢alion lo youlh. families and other caregivers,. To promote education of diabetes healthca￿ teams wod¢Jw"Ile". To foster diabetes research., and To prepare and disseminate clinical practice guidelines and standards. Page 4 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Our Valuas Excellence In care. based on rigorous and ethical research wth respect for the indiwdual child, adolescent and family and by creating, evaluating and disseminkn'ng diabetes knovAedge. Collaboration The Society collaborates %Mth national and intemational patient and Professional organisations, healthcare providers, policy makers and companies that make products or provide services for children with diabetes. Advocacy For children and caregivers lo improve awareness that diabetes is different for ¢hildren ¢ompared lo adults,. lo end dis¢riminalion based on a child's diabetes. and to obtain increased funding for diabetes treatment, research and prevention. To promote the Care of children and 8ddescenl$ wth all foms of diabetes mellilus., To be an advocate for children and adcAescents with all loms of diabetes mellilus". and To encourage and support basic. clinical. epidemiological. healih. economic and all other relevant research concerning paediatric and adolescent diabetes mellitus. Publlc Beneflt Please see bel¢)w a summary of the principal aclivities and accomplishments for the year which ISPAD has carried out for the public benefft. In the furtherance of these objectives, the ISPAD Trustees have complied wth the duty in Seth'on 17 of the Charitie5 Act 2011 to have due regard lo the Charity Commission's published general 8nd relevant SU￿seCtor guidance conceming the operatson of the PublK Benefrt requirement under that Act. PRINCIPAL ACTIVITIES AND ACCOMPUSHMENTS Education The extenswe Clinical Practice Consensus Guidelines (26 chapter51, published in 2022, conts'nue lo be promulgated and made availat4e on the Society's websrte and published in Pediatric Diabetes, the Society'5 former joumal. The Clinical Practice Consensus Guidelines are an upl&dale ￿ference for all those concerned th the management of childhood diabetes woddwide and indude guidelines for under resourced areas. The Guidelines were developed and wrrtlen by members of the Society, led by an editorial team. This last comprehensive revision consists of 26 chapters and over 250 authors Iglobal distribution. early career and senior, diverse professional background, and person5 Wrth diabetesl. In addition. an external project officer was appointed lo lake a lead In supporting the edrtorial team to ensure the guidelines meet inlemalional standards for clinical guidelines and ensure hamionisation of recommendations. content. language and evidence grading across chapters. The Guidelines are evidence•based and are vffltten using a review process involving input from the entire membership, led by our excellent and enlhusiaslic volunteer editorial team. A copy of each chapter is available for download by anyone Inol only for the members) al no c05t from our websrte www.ispad.org. ISPAD has been collaborating with partners on the translation of the ISPAD 2022 Guidelines into various languages lo fa¢ilitsle even broader access. By today. the Guidelines are available English, French, Spanish, Portuguese and Hindi. In addition, translations into other languages are er￿ouraged no charge from ISPAD who coordinates these efforts to avoid redundant translations. Page S THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 ISPAD'S Clinical Practice Consensus Guidelines are the only comprehensive set of clinical recommendations for children, adolescents, and young adults wlh diabete5 worldwdel As some chapters are subject lo a rapid lum- over and require an earty update. six chapter5 of ISPAD'S Clinical Pracbce Consensus Guidelines were revised and updated accordingly in 2024. The chapters from the ISPAD Clinical Practice Consensus Guidelines 2024 set that has been published in ISPAD'S offiaal Journal (Hormone Research in Paediatricsl are listed below {six chapters and one editoriall.. Chapter 02.. Screening, Staging. and Strategies lo Preserve Bet&Cell Function in Children and Adolescents Type 1 Diabetes Chapter 03.. Type 2 Diabetes in Children and Adolescents Chapter 08.. Glycemi¢ Targets Chapter 09.. Insulin and Adjunctive Treatments in Children and Adolescents wth Diabetes Chapter 16.. Diabetes Technologie5.' Insulin Delivery Chapter 17.. Oiabeles Technologies.. Glucose Monitoring ISPAD Clinical Practice Guidelines 2024.. EdTtorial Educats'onal courses are offered to the membership both, in virtual forniat (Webinars, online learning tools) and in person Annual Conference. Science &hoc4 for Physician$ and Science Sch¢)ol for Healthcare Professionals. as well as Postgraduate Courses. Advocacy ISPAD collaborates Closely Nwth 'Life for a Child, and'changing Diabetes in Children, major programs whose aim is lo improve access to essential diabetes medicines linsulinl and supplies for children in the developing wodd. ISPAD also collaborates wth 'Action4Diabetes', a charity providing health to disadvantaged young people th Oiabetes in South-East Asia. ISPAD also collaborates wth organisations providing help in areas hit by humanitarian crisis- 'Inlemational Alliance for Diabetes Acts"on IIADAI. _ to support them with guidelines needed to deal with persons suffenng from diabetes In areas Ythoul regular diabetes care and supply due lo humanilarfan cri81S. ISPAD is a society that opened its membership for advocate$ and offers a separate membership for advocates. Sclence The Annual Conferences Inv(Ave presentation of Te5ear¢h activib"es, stslfrof-the-art lecture5 and topic Specific symposia. In 2020 and 2021. ISPAD'S Annual Conference took place virtually over a three-day meeting in October 2020 and 2021 wth 1.285 and 1.414 part]'cipants respectively. In 2022. the Annual Conference was held in person in Abu Dhabi, United Arab Emirates October 1>16. In total, the meeting brought together 1058 attendees 1781 face-tO•face, 277 virtuall, and 369 scientsfic abstracts were submitted. In 2003, the Annual Conference was held in Rotterdam, Netherfands wth a total of 1.623 Attendees from 100 countries and 489 abstracts submitted by authors form all parts of the world. In 2024, the Annual Conference Wds held in Lisbon, Portugal with a lotsl of 1.830 delegates attendees from 83 countn.es and 636 abstracts submitted by authors form all parts of the wodd. The attendance in 2024 has been the best ever. Al the meeting in Lisbon the organisation celebrated it's 50th anniversary, showng the long standing need for the society as such and the success throughout all those years. ISPAD organi5es and run5, With volunteer experts. an annual research-orienled Science School for Physicians (held in person in Pittsburgh. Pennsylvania. USA in September 20241. as well as a Science School for Allied Healthcare Professionals working in diabetes Iheld in person in Lisbon. Portugal in October 20241. Applications are very competits've for both science schools each year and indude parb'cipants from all over the worfd. Visiting Fellowship5 allow young physicians and healthcare PTofe5sionals lo study research techniques and prepare them to set up research proposals, erthei in collaboration with the centre in which they study, or lo initiate research in a similar area in a MO￿ independent manner by providing hands-on experience in an estsblished Centre of Excellence of research in the domain of interest Ap￿￿1canlS present a research proposal Page 6 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 for their study as well as references, letters of support from their hospital or university and from the head of the research centre to ￿lch they are ap￿￿ng (directed by an ISPAD member) attesting to the applicant's acceptance at the centre to pursue the research project as presented. The accepting ISPAD member volunteers their time and centre resources for the project. The funds allow the recipient lo travel lo the centre and provide support for accommodation. Since 2017 ISPAD collaborates wth Breakthrough T1 D Ifomierty the Juvenile Diabetes Research Foundation IJDRFII and from 2024 onwards, the funding of the Research Fellowship increases to 25,00￿0,000 dollars range lo fund up lo 11 fellow5. and since the calendar year 2019, 10 Allan Drash fellowships, of 7,500 dollars each. The applications are revIe￿ed by the Trustees and the Advisory Committee rank them on the quality of the application and polentsal benefits to Ihe applicant The successful recipient provides ISPAD ￿th a report on the project and is encouraged to submit an abstrad to the Annual Conference andlor submit a manuscript lo the ISPAD Journal. Grants from General Funds Travel grants are for young physicians and heahh¢aTe professionals vthose abstracts have been accepted for presentation al the Annual Confefence. ISPAD support travel grants Iscaleil according to geographical localionl and special travel grants (full payment of travel, registration and accommodab'on for members from the devdoping worldl. The abslracl quality (scoring 49 per reviewin9 process by Ihe Abstract Committee) as well as the country of residence and profession were part of the selecbon criteria for 3llo¢aling these grants. Applic31ions from Lower Income Countries las per Worfd Bank dassificatsonl and Allied Healthcare Prefessionals were explicitly encouraged. Grants Supported by Funds from Restrlctod Grants Grants were obtained for the Science Schoc4 for Physicians for a 5-day course for 19 young physician scientists in 2024 to learn how lo design a research study, apply pToper stslislics and wnle grants. These grants were provided in 2024 by Breakthrough T1 D Ifomedy JDRF). Volunt88rs Members of the Society participate in all aspects of the Society e.g.: serving on the Advisory Council serving 85 convener and organi5ing committee members for the Annual Conference serving on the Scientific Commrttee reviewng abstracts for the Anntjal Confe￿nce acting as faculty for the Science Schools and post graduate course$ serving on wriii'ng committees for the Clinical Pracbce Guidelines serving on special interest group advocating for children diabetes at local. regional and intemats.onal levels working wlh sponsors lo increase contn"bulions attending the Annual Conference (primary fvn&raising eventi serving as preceptors for Visits'ng Fellows providing leadership in diabetes care for children and adolescents localty. Members The International Society for Paediatric and A(l(Aescent Diabetes has members from more than 100 countries. A membership directory can be found on the ISPAD websrte IwvAv.ispad.orgl. Page 7 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 FINANCIAL REVIEW AND RESULTS FOR THE PERIOD Financial Review The current penod 15 for the 12 mOnt￿pen0d ended 31 December 20241'2024'1. The prior period is for the year ended 31 December 20231,2023,). During the financial period 1 January 2024 to 31 December 2024. expenditure totalled £1,339,027 12023.. £803,622) and income was £1.185,503 {2023.' £966.9651. As income is over £1.000,000 the charity is required to have an audit. The comparative figures for 2023 have been amende(J since the 2023 accounts were filed, please see note 4 for details. Our financial goals are to maintain sufficient funds held in reserve to assure our continued existence under difficult financial situations Ipoor income years, and unusual economic times), while we continue 10 5UPPOrt funding for Science Schools, Post Graduate Courses. the Allan Drash Clinical Fellowship. Research Fellowship, Travel Grants. Hormone Research in Pae(Jiatrics, Gui(Jeline officer. Memberships. and special inrtiatives. One of the challenges of holding our Annual Conferences in different locations around the wodd is the wdely varying costs and benefits from them. The 2018 Conference in Hyderabad, India was a successful Conference in raising awareness across the wider region, but resulted in a negative balance. while the 45th Annual Conference in 8oslon. USA in 2019 resulted in a posrtive balance. The Annual Conferences in 2020 and 2021 were both virtual, wth good attendance and they resulted in posib.ve balances. The Annual Conference in 2023 look place in Rotterdam, Netherlands and was a very successfvl meeting and resulted in a positive balance. The Annual Conference in 2024 took place in Lisbon, Portugal and was a very successful meeting wth the highest number of attendees in our history. The followng years our conlerence will move to Montreal, Canada in 2025 and Rio de Janeiro, 8razil in 2026, un¢ertainknes in temis of financwdl sucees$. A crucial element of our charrtable aims is lo facilrtale access lo science and educats"on, especially for young health professionals involved wrth diabetes across all countries of the world. To this end we support travel grants (scaled according to geographical location) and special travel grants (full payment of travel, registration and accommodation for members from the devdoping worfdl. StartJ'n9 from July 1, 2020, ISPAD has reduced membership and re9istratson fees for members from Upper-middltrincome countries as well as waived membership lees for Lo￿lne0Me countries. Reserv9$ Poll¢y Our policy is to maintain reserves of sufficient funds to provide ongoing support for at least one year of Charity activity. ISPAD currently aims to keep reserves of £700.000 . The balance of total reserves al the year end was £1,270,862 12023.. £1,434,386) of which £958,509 12023.. £1,116.7951 was free reserves, this compares wlh £1.185,503 of lolal income in the period ended 31 December 2024 12023". £966,965), and £662,295 12023.. £486.4131 was ￿$triCted. Conference income is very unp￿￿1¢tsb1e and the current financial climate demands that we hold a slighly increased reserve. This is considered to be prudent also in light of the fact that the next 40 conferences wll take place in Northern and Southem America and corporate sponsorship has become more challenging lo obtain. The comparative figures fow 2023 have been amended since the 2023 accounts were filed, please See note 4 for details. Investment Policy and ObjactiV8S The overriding philosophy and policy is that the Charity will take only minimal risk in order to Preserve fvnds. The objectives are to garner when possible, reasonable interest on hdd lunds wihoul placing reserves or day-ltrday fund5 at risk. Page 8 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Income: During 2022, we again observed an increase in total membership numbers, mainly because the in-person conference in Abu Dhabi raised local interest and new members form the area. Our Annual Conferences in Rotterdam 2023 and Lisbon 2024 were very ￿11 attended and also affected our membership numbers. The Annual Conference in Lisbon 2024. resulteil in a pOs￿"ve balance. This was both because of an increase in number of attendees and increase in sponsorship income. positively influenced by the realisation of our meeting in Europe. ISPAD wll continue lo %wrk hard in order to increase the numbers of members. both in specific regions as well as worldwide. Regarding Corporate Membership and Sponsorship. vthi¢h are extremely important sources of income for ISPAD, the Situation is still uncertain. So far, all key $pon$or$ have maintained their ¢ommilment$. Still, we are aware that the siluation for many of our Corporale collaborators are uncertain. and should not take their support for granted for the upcoming years. Exp•ns•s: There are still, and VAII most likely a￿VayS be, uncertainties wth respects to the allo¢alion and formal of several of ISPAD core activities. This includes our science schools, both for physicians and healthcare providers, the ASPED-ISPAD-Academy, COIC Iraining, ADECA training and finally the Alan Drash fellowships. The restricted funding from different sponsors for these activities V￿11 depend on the aclivilies. formal lin-person or virtuall. These aclivikn'es are of Course very important for ISPAD as soc*ty, and %%e have to be flexible, dynamlc and pra9malic to maintain as many as them as well. In summary. there are more fisks and uncertainties than usual in the current situation. Nonetheless, the financial $itualion is very safe wthin the fiscal year 2024 due to headroom given by the level of reserves. The Tru8tees undertake detsiled planning and forecasting across the year. Due lo this, the Trustees believe that the Charity's financial resources. strong reserves position an(J conlingeney planning is sufficient lo allow the Charity lo continue as a going concem for the foreseealle fvture. being al least 12 months from the date of approval of these financial statements. There are no material uncertainties about the ability to continue and therefore the financial statements have been prepared on a going concem basis. Looking ahead ISPAD has increased engagement ￿th patient advocacy and team membership groups during this reporbng year, and has encouraged them to meet al our Annual Conferences and lo publicise the work and mission of ISPAD. In the 2024, the Society celebrated its 50th anniversary in the annual meeting in Lisbon, Portugal, with the highest number of attendees ever. The next Annual Conferences will take place in Montreal, Canada in 2025 and in Rio de Janeiro, Brazil in 2026. Due lo the COVICk19 pandemic. the inlemalional ¢onfli¢ls and climate changes. the financial situation is sb'll challenging and rules and regulations for support from industy have changed making rt more difficult for ISPAD to receive corporate membership fees or specffic grants. We are grateful for those who have been able to continue to support ISPAD. For this reason, ISPAD offers different levels to become a corporate member or Sponsor, wlh different benefits. ISPAD. to enhance rts Telalion5hip with companies, organizes a specific and strategic meeting {Corpor8le Advisory Board Meeb"ng) 8nnu81ty all companies during ils Winter Meeting. Since 2019, this meets'ng has been taking place adjacent to the ATTD (Advanced Technologies and Treatments in Diabetesl in order to enable maximum industy attendance. Furthemiore the Executive Board Members meet ith industry partners at the Summer Meeting (taking place at ADA - American Diabetes Association) and of course during the ISPAD Annual Conference in autumn every year. The invoiced year for corporate membership is now the calendar year (January to December). To Strengthen the financial commitment wlh our corporate partners even more. we plan to offer three-year corporate memberships in the upcoming years. Page 9 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Membership payments are becoming increasingty important The number of lapsed members might be significantly reduced by improving the payment process and the possibilities to interact wf(h other members. In order to improve payment of membership fees and to enhance the member experience and modernize its online presence. ISPAD has launched a new membership sofNvare and an upgraded website in 2024. After a decline In membership during COVIt>19 Pandemic. V•E coukl now stabilize our Membership and work on slightly increasing the membership income in 2025. We still anb'cipate that ISPAD wll likely face global inflation in the upcoming fiscal years. We expect that some corporate members and sponsors may withdraw as their financial situation Is uncertain. Although other5 may become new members. we may see a reduction in total corporate members and sponsorships. Therefore, maintaining reserves ol sufficient funds are more important than ever for ISPAD. We have also inits'aled a revised accounting system for invoi¢ing to be performed by K.l.T. Group in wnjun¢ty'on th and approval by the ISPAD T￿asUrer. This system is deS￿ned to provide redundancy and avoid missing opportunities for ISPAD funding. Charlty Govemanco C<>de ISPAD aims lo address the seven https'.1￿.¢harity90Vern8ncecO￿e.OrglenMrQnt-page prirKiples of the Charty Governance Code.. 1. Organisational purpose.. to facilitate the mission of ISPAD to improve the lives of children, adolescents and young adults wlh diabetes woddw"de. To do this we provide forums. both WTrtten (guidelines, e-Learningl and face-lo-face Iscienlific meetings, science schools for physicians and for allied healthcare professionals. and poslgraduale courses). lo physicians and healthcare professionals vh)0 prowde care for young people wlh diabetes. We have three main pillars to achieve our mission.. science. educats'on and advocacy. 2. Leadership., the Trustees comprise an Executive Board and are advised by an Advisory Committee. We take collective responsibility for the 8oard'5 decisions. The role5 of each Tru51ee are dearly identified (Winter Exe¢ukn've Meeting February 20201. Since 2017, the Executive Board now includes a Communications Director lo facilitste effective communication wlh the membership and community. 3. Integrity,. the Executive Board acts integrity and is conscious of how it is perceived by the membership and the public. A corporate liaison officer was appointed in February 2018 to assist with communication and perception in the community. the "Diabetes Online Community. including consumer'bloggers We facilitate their meeting5 al our Annual Conference and meet wlh them al meetings organRed by the consumer organization Child￿n With Diabetes (February 20201. Conflicts of interest a￿ decla￿d. 4. Decision•making, risk and control,. the Board makes SU￿ that operational plans and budgets are in line wth the charity's purpose. The Board invested in forward planning by expenses for representatives to meet and teach in India12016-20201, the country with the second largest number of children with diabele5, and in Africa12019, 2020.2022,2023,2024}. 5. Board effectiveness,. the Board acts as an effective team and encourages members of the Advisory Board lo set up Special Interest Groups at the Annual Conference in October 2017 onwards. Trustees are reflective of their performance and discuss areas that can be strengthened. 6. Equality, Diver5ty and Inclusion", the Board encourages diversity in the membership of commrttees, and In special ntsn-physi¢ian posibons on the Advisory Board. 7. Openness and accountabilrty,. the Board communicates wth the membership by the Annual General Meeting and by monthty newsletters sent by email. The Presidenl vffltes special messages since 2017 which can be Sourced on the Swiety's websrte. The Annual Report 15 circulated lo the Membership and 15 available to the Public. Page 10 THE INTERNAnoNAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 TRUSTEES. REPORT ICONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Statement of Trustees. Responsibilities The Trustees (who are also directors of the Intemational Society for Paedialric and Adolescent Diabetes for the puywigiuI5company lawl are responsible for prepanng the Truslee5' Annual Report and the financial stslements in accordance appliCat￿e law and Unrted Kingdom Generalfy Accepted Accounting Practice (United Kingdom Accounting Standards). Company law requires the Tfustees to Prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the slate of affairs of the Chantable Company and of the incoming resources and application of resources. including the income and expenditure. of the Chartsble Company for that period. In preparing these financial stalemenls, the Trustees are required lo.. select suitable accounting policies and then apply them consistendy., observe the methods and princiFAes in the Charrties SORP.. make judgments and eslimales that are reasonable and prudent.. stsle whether applicable UK accountsng standards have been followed. subject to any material departures disclosed and explained in the financial stslemenls'.and prepare the financial statements on the going concem basis unless il is inappropriate to presume that the Charitable Company wll continue in bLbsine$$. The Trustees are responsible for keeping adequate accounting records that are sufficient lo show and explain the Charitable Company's transactions. disclose reasonable accuracy at any tsme the financial position of the Charitsble Company an¢J enable them lo ensure Ihal Ihe financial stslements ¢ompty with the Companies Act 2006 and the provisions of the Charity's constitution. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable sleps for the prevention and detection of fraud and other irre9ularib'es. The report of the Trustees has been pfepared in accordance with the special provisions relating lo small companies subject lo the small companies regime wthin part 15 of the Companies Act 2008. Approved by the Board of Trustees of The Internats'onal Society for Paediatric and Adolescent Diabetes on 3111012025 and signed on its behalf by.. Dr Sabln8 Hof8r Trust00 Page11 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES Opinion We have audited the financial stslemenls of The International So¢￿ty for Pediatric and Adolescent Diabetes Ilhe 'company'l for the year ended 31 December 2024 which Comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Cash Flows, the Statement of Changes in Equity and the related notes. including a summary of signifficant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standard5, Including Financial Reporting Slanllard 102 'The Financial Reporting Standard applicabie in the UK and Republic of Ireland, (United Trfjngdom Generally Accepted Accounb'n9 Pracb¢e}. In our opinion, except for the possible effects of the matter described in the basis for qualrfied opinion 5èclion of our report the financial slatemenls.. give a true and fair view of the state of the charitable company's affairs as al 31 December 2024 and of 115 incoming resources and applicalim of resources. induding its income and expenditure for the year then ended., have been properly prepared in accordance ￿￿th United Kingdom Generally Accepted Accounfjng Practice,. and have been prepared in accordance wth the requirements of the Charth'es Act 2011. Ba818 for oplnlon Wè conducted our audit in accordance with Intemational Standards on AUd￿ng IUKI IISAS IUKII and applicable law. Our responsibilities under those slandafds are further described in the Auditor's responsibilities for the audit of the financial slalemenls section of our ￿pOrL We a￿ in¢Jependenl of the charitsble company in accordance th the ethical requirements that are ￿levant to our audrt of the financial Statements in the United Kingdom. including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilits'es in accordance wth these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Matorlal uncertalnty r8lat8d to golng concern We draw attentson to note 2 in the financial statements. which indicates that wlhin the next 12 months from the signing of the accounts that the charitable company ￿11 ￿lOCate out of the UK. As slated in note 2 these events or conditions, along wth the other matters as sel forth in note 2, indicate that a material uncertainty exists that may cast significant doubt on the company's abih'ty to continue as a going concem. Our opinion is not modified in respect of this matter. In auditing the financial statements, have conduded thal the trustee's use of the going concem basis of accounting in the preparation of the financial statements is appropriate. Our evaluation of the trustee's assessment of the entity's ability lo continue to adopt the going concern basi5 of accounting included reviewing the entibes accounts line by line to ensure the appropriate accounting policies have been followed due lo the charity no longer having a p￿sence in the UK. Our responsibilities and the resF*Jnsibilth'es of the trustees %Mth respect to going concern are described in the relevant sections of this report. Page 12 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES (CONTINUED) Other inforniation The other inlormation comprises the infomiation indudetl in the Annual Report other than the financial stslements and our Audilorfs Report Ihereon. The Trustees are responsible for the other informab'on Contained thin the Annual Report. Our opinion on the financial statements does not cover the other information and. except to the extent otherwse explicitly stated in our report, we do not express any form of assurance condusion Ihereon. Our responsibility is lo read the other infornialion and, in doing so, consider whether the other information is materially Inconsistent with the financial statements or our kn￿ledge obtained in the course of the audit. or olherwse appears to be materially misstated. If we identify such material in¢onsislen¢ies or apparent material misstatements, we are required to determine vthether this gives rise to a material misstatement in the financial statements themselves. If. based on the work y￿ have performed, we conclude that there is a material misstatement of this other information, are required to report that fact. We have nothing to report in this regard. Mattern on whlch r•qulr•d to report by èxcèptlon Except for the matter described in the basis for qualified opinion section of our report, in the light of the kno%%ledge and understanding of the charity and its environment obtained in the course of the audit, we have not identified material misslalemenl in the trustees report. Arising solely from the limitation on the scope of our work ￿lats'n9 lo memberships an¢J travel grants.. We were unable lo delerniine %thether adeql￿te accounting records have been kept We have nothing lo report in respect of the followng matters in rdalion lo ￿1¢h the Charities (Accounts and Reportsl Regulations 2008 requires us lo report to you rf. in our opinion". return5 adequate for OUT audit have not been received from branches not visited by us., or the financial statements are not in agreement the accounting records and relums.. or certain disclosures of directors, remunerabon specthed by law are not made., Re8ponslbilitie8 of trugtses As explained more fully in the Trustees. Responsibilities Statement, the Twslees (who are also the directors of the charitable company for the purposes of company lawl are responsible for the preparation of the financial gtalemenls and for being satisfied that they gwe a true and fair wew. and for such internal control as the TrLJslees delemiine is necessary lo enaNe the preparation of financial stslements that are free from material mi$slalemenl, whether due to Iraud or error. In preparing the financial slalements. the Trustees are responsible for 3$5essing the charitable company's ability to Continue as a going Concern. disclosing. as ap￿1¢able. matters related to going ¢on¢em and using the going concern basis of accounting unless the TnJstees ether intend to liquidate the charitable company or to cease operations, or have no realistic alternatt've bLrt to do so. Page 13 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES (CONTINUED) Auditorfs responsibilities for th8 audit of thg financial slatemonts We have been appointed as auditor under section 144 of the Charities Act 2011 and rewrt in accordance wlh the Act and relevant regulations made or having effect thereunder. Our objectives are to obtain reasonable assurance al)out vknelher the financial statements as a whole are free from material misstslemenl. vA)elher due to fraud or error. and to issue an Auditor's Report that includes our opinion. Reasonable assurance 1$ a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAS IUKI wll a￿yS detect a material misstatement then it exists. Misstatements can arise from fraud or error and are considered material if, individualty or in the aggregate, they could reasonably be expected lo Influence the economic decisions of users taken on the basis of these financial slalemenls. Irregularities, including fraud, are instances of nonfincomo Transfers between funds 1158.024) 1262) 15,5001 262 1163,S241 163,343 15 Not movement In funds 11S8,286) 15,2381 1163,5241 163,343 Raconclllatlon of funds: Total funds brought forward Nel movement In funds 1.116.795 {158.286) 317,591 15,2381 1.434,386 1163,5241 1,271,043 163,343 Total funds carriod fopward 9S8,509 312,353 1.270,862 1,434,386 The notes on pages 20 to 36 fom part of these financial statements. Page 16 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limitad by Guarants•l REGISTERED NUMBER: 06641016 BALANCE SHEET AS AT 31 DECEMBER 2024 2023 As ￿Stated 2024 Mot• Curr•nt assets Debtors Cash al bank and in hand 12 495,3SO 1,742,738 141,699 7,832, 702 2,238,0fjfj 1,974,401 Current Ilabllltl•s Creditors." amounts falling due wthin one year 13 {940,4921 (503.674? Not curront a88ot* 1,297.596 7,470, 727 Total a88Ots less current Ilabllltles 1,297.$96 1,470, 727 Creditors.. amounts falling due after more than one year 14 {26.7341 (36,341) Total net assots 1,270,862 1,434,386 Charlty funds Restricted funds Unrestricted funds 15 1S 312,353 958,509 317,591 7, 116, 795 Total funds 1,270,862 1,434,386 The entity was entitled to exemption from audit under section 477 of the Companies Act 20C6. The members have not required the entity to obtain an audrt for the year in question in accordance wlh section 476 of the Companies Act 2006. However, an audit is required in accordance ¥Mth sectson 144 of the Charities Act 2011. The Trustees acknovAedge their Te5ponsibilities for com ￿YIng the requirement5 of the Act wth respect lo accounting records and preparation of financial stslements. The financial statements have been prepared in accordance vAih the provisions applicable to entities subject to the small companies regime. Page 17 THE INTERNAnoNAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Limitad by Guarants•l REGISTERED NUMBER: 06641016 BALANCE SHEET (CONTINUED) AS AT 31 DECEMBER 2024 The financial statements were approved and aLrthorised for issue by the Trustees and signed on their behaff by.. on 3111012025 Dr Sabino Hofor Trustee The notes on pages 20 10 36 form part of thvae financial statements. Page 18 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2023 2024 As restaled Noto Cash flov￿ from operating activities Nel cash from operab.ng activities 17 {89.9641 260,425 Chango in cash and cash •quivalents in the year Cash and cash equivalents al the beginning of the year {89.9641 1,832.702 260.425 7,572.277 Cash and cash equivalents at th• 8nd ol the year 18 1,742,738 1,832, 702 The notes on pages 20 to 36 fomi part of these financial statements Page 19 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Goneral Infomiation The International Society for Pediatric and Adolescent Diabetes IISPADI is a charitable company, limited by guarantee, (registration number 06641016 England & Wales) and the Charity Commission (charity number 11269271. The registered office address is Harrison Clark Rickerbys Limf(ed, Ellenborough House, Wellington Street, Cheltenham, Gloucestershire. GL50 1YD. Accounting policies 2.1 8a818 of preparatlon of flnanclal stst¢monts These financial statements present inforniation aboLrt the Charity as an individual undertaking. The Current period is for the year ended 31 December 2024 1'2024'1. The prior period is for the year ending 31 December 2023 {'2023'). The financial slalemenls have been prepared in accorilance wth the Charities SORP IFRS 1021 Accounting and Reporting by Charities.. Statement of Re¢ommended Pra¢lice applicable lo charities preparing their accounts in accordance the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 (effective 1 January 20191. the Financial Reportin9 Standard applicable in the UK and Republic of Ireland IFRS 1021. the Companies Act 2006 and the Charities Act2011. The Inlemalional Society for Pedialric and Adde$cenl Diabetes meet$ the definth'on of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy. 2.2 Golng concèm The Trustees have undertaken detailed Flanning and forecastr'ng and continue lo closely monitor persistent global uncertainties. induding inflationary pressures and geopolrtical instability Although the Trustees observed a posrtive conference income in 2024. there are still uncertainties over future corporate income and income and cost5 associated vthh conferences and other educational programs involving travel and10giStical expenses. Despite these challenges, the Trustees believe that the Charitys financial resources, strong reserves posth'on and contingency F4anning is sufficient to allow the Charity to continue as a going concern for the foreseeable fvture. being at least 12 months from the date of approval of these financial statements, no￿thstandIng, there is material uncertsincy in relation lo the going concem of the charity as the charity plans lo move out of the UK In either 2026 or 2027. 2.3 Income Income is recognised in the financial statements when the Charity has entidement lo the funds, f( Is probable that the Income will be received and the amount rAn be measured reliably. Membership income is wognised in line the financial year. Membership income for future years is deferred. Page 20 THE INTERNATIONAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 ACCOUn￿ng poll¢l•$ {¢ontlnuod} 2A ex￿nditUre All expenditure is accounted for on an accruals basis. Support costs are apportioned to cost activities based on the esbmated amount attn'butable to that cost in the year on the basis of the estimated time spent on that actsvity. The irrecoverable element of VAT is included with the item of expense to which il relates. Charitsble activities comwse all expendiiure incurred directly relating to the objects of the Charity. Granls are r￿QgnIsed vknen a con$tru¢tive ot4ig*ion arises thal results in the payment being unavoidat4e. Govemance costs include the c¢)sls connected the Charity's consts"lutional and stslulory requirements. Charitable activities are ¢ost$ in¢urred on the company's operations, including $uppgrt cost8 and costs relaii'n9 to the governance ol the company apportioned to charitable activities. 2.5 For•lgn currènclos Monetary assets and liabilities denominated in foreign Currencies are Iran$l*e(l into sterfing al rates ol exchange ruling at the reporting date. Tran$a¢lion$ in foreign curren¢ie$ are translated into sterling al the rale ruling on the date of the Iransaclion. Exchange gains and losses are recognised in the Statement ol Financial Acts'vilies. The functional currencies of ISPAD are considered to be Euros and US Dollars because these are the currencies used by the members of the Society in the primary economic environrnent in which the charity operates, Euiope and the rest of U)e wodd. The financial statements are presented in pouniJ8 sleding. 2.6 Taxatlon As a registered Charty the entrty is entiljed lo taxation exempts'ons on all ils income and gains, propedy applied for its charrtable purposes. 2.7 Dgbtor¥ Trade and other debtors are recognised at the setdement amount after any trade discount offered. Prepayments are valued al the amount prepaid. 2.8 Ca$h at bank and In hand Cash is represented by cash in hand and deposiis wlh ffinancial institutions. 2.9 Creditors Creditors are recognised once there is a legal or constructive obligation that commrts the Charity to the obligation. Page21 THE INTERNAnoNAL SOCIETY FOR PEDIATRIC AND ADOLESCENT DIABETES IA Company Llmltgd by Guar4ntso1 NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 ACCOUn￿ng poll¢l•$ {¢ontlnuod} 2.10 Finanelal instrumènts The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequendy measured at their settlement value. 2.11 Fund *¢¢ountlng Unrestricted funds expendable at the dIscret￿n of the Twslees in fvrtherance of objectives and administration ol the Charity. Restricted funds are to be used for specthed purposes laid doym by the donor. Expenditure for thoyè purposes is charged lo the restn"¢ted fund. Crltl¢al accounllng g$tlmalgs and arna¥ oljudggmgnl Preparation of the financial statements requires management lo make any significant estimates and judgements vh)ere necessary. Critical accounting eslimales and assumptions.. Impa5rment of debtors The charity make5 an esb'mate of the recoverable value of membership debtors. When assessing impaimienl management considers historical experience. See note 12 for the nel carrying amount of debtors. Prlor year adjustmant A prior year adjustment was made for a the back